Literature DB >> 17952043

Pathogen subversion of cell-intrinsic innate immunity.

Craig R Roy1, Edward S Mocarski.   

Abstract

The mammalian immune system has evolved under continuous selective pressure from a wide range of microorganisms that colonize and replicate in animal hosts. A complex set of signaling networks initiate both innate and adaptive immunity in response to the diverse pathogens that mammalian hosts encounter. In response, viral and microbial pathogens have developed or acquired sophisticated mechanisms to avoid, counteract and subvert sensors, signaling networks and a range of effector functions that constitute the host immune response. This balance of host response and pathogen countermeasures contributes to chronic infection in highly adapted pathogens that have coevolved with their host. In this review we outline some of the themes that are beginning to emerge in the mechanisms by which pathogens subvert the early innate immune response.

Entities:  

Mesh:

Year:  2007        PMID: 17952043     DOI: 10.1038/ni1528

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  85 in total

1.  Immune evasion strategies of Porphyromonas gingivalis.

Authors:  George Hajishengallis
Journal:  J Oral Biosci       Date:  2011

2.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

3.  A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle.

Authors:  Qing Yao; Jixin Cui; Yongqun Zhu; Guolun Wang; Liyan Hu; Chengzu Long; Ran Cao; Xinqi Liu; Niu Huang; She Chen; Liping Liu; Feng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

4.  Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.

Authors:  Nobuhiko Kamada; Kei Sakamoto; Sang-Uk Seo; Melody Y Zeng; Yun-Gi Kim; Marilia Cascalho; Bruce A Vallance; José L Puente; Gabriel Núñez
Journal:  Cell Host Microbe       Date:  2015-04-30       Impact factor: 21.023

5.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 6.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

7.  Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.

Authors:  Benjamin K Billips; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

8.  A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors.

Authors:  Jianning Ge; Hao Xu; Ting Li; Yan Zhou; Zhibin Zhang; Shan Li; Liping Liu; Feng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

9.  Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Authors:  Karen Buttigieg; Stephen M Laidlaw; Craig Ross; Marc Davies; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

10.  Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.